Saturday 17 October 2026 Export PLX’s income statement to Excel — free account

Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $52.7 million, down 1.23% from fiscal 2024. In the quarter to June 2026, revenue grew 27.1%, EPS grew 2,281.0% and free cash flow fell 94.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

2.62 0.08 −2.96%

Follow PLX

Alert me

Market cap: $217.5M
P/E: 10.9×
Fwd P/E: 10.2×
Dividend yield: —
F-score: 3/9
Altman Z: −3.05
Beneish M: −0.15
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	31.23%	27.27%	(14.44%)	12.64%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	7	7	3	6
ROA Full definition →	20.07%	17.40%	(8.48%)	7.50%
ROIC Full definition →	48.48%	80.14%	(19.92%)	16.91%
Return on Tangible Assets Full definition →	28.58%	23.91%	(14.66%)	10.95%
Average Days of Receivables Full definition →	74.72	14.04	61.17	85.14
Free Cash Flow per Share Full definition →	0.10	0.16	(0.17)	(0.15)
Free Cash Flow Full definition →	7.67	13.00	(13.63)	(11.69)
Capital Expenditures Full definition →	(2.25)	(2.09)	(1.64)	(1.66)
Other line items
Cash ROIC Full definition →	6.80%	10.92%	(17.21%)	(14.21%)
Accounts Receivable Turnover Full definition →	6.21	16.60	8.98	7.44
Accounts Payable Turnover Full definition →	0.95	0.94	1.10	1.21
Inventory Turnover Full definition →	0.93	0.92	1.15	1.37
Average Days of Payables Full definition →	436.92	412.97	339.86	285.61
Days of Inventory on Hand Full definition →	474.65	484.87	347.91	295.43
Tax Rate Full definition →	(0.19)	(0.20)	0.18	(0.17)
Research and Development Expense of Revenue Full definition →	24.66%	28.17%	37.10%	29.20%
Selling, General and Administrative Expense of Revenue Full definition →	15.65%	15.88%	22.15%	18.04%
Share Based Compensation of Revenue Full definition →	2.80%	3.00%	4.35%	3.59%
Operating CF/Net income Full definition →	0.52	0.98	1.82	(1.86)
Depreciation/Fixed assets Full definition →	0.29	0.30	0.30	0.30
Capex/Depreciation Full definition →	(1.44)	(1.37)	(1.12)	(1.18)
Revenue per Share Full definition →	1.01	0.96	0.67	0.78
Operating CF per Share Full definition →	0.12	0.19	(0.15)	(0.13)
Capex per Share Full definition →	(0.03)	(0.03)	(0.02)	(0.02)
Capex to Sales Full definition →	0.03	0.03	0.03	0.03

Show all line items

Columns are period end dates

Stockrow Weekly